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CHAPTER

I

THE PROBLEM
A phase of investigation receiving a great deal of
attention today is the relationship of diet to the increased
incidence of vascular disease.

This disease represents the

foremost long-term problem in the diabetic patient.
Diabetes mellitus predisposes to earlier onset and more
rapid progression of atherosclerosis when compared to a
non-diabetic, atherosclerotic study group. The following
questions posed by Kinsell 64 summarize the problems involved
when applied to the diabetic patient,

(l)

Are the degene

rative changes associated with diabetes related to qualitative
or quantitative abnormalities of the diet?

(2)

Could

specific dietary modification prevent or improve the
situation?
Statement of the nroblem.

Research has Indicated

that the dietary fats differ in their effect on serum cho
lesterol and probably on atherosclerosis.

A study reported

by Cochrane2® illustrates this difference.

A small group

of diabetic patients, and one patient with familial hyper
cholesterolemia, were maintained on a mixed (non-formula)
diet, isocalorically substituting vegetable lipids for fats
of animal origin.

This substitution in a high protein,

high fat, diabetic diet, with the total protein, fat, and

2
carbohydrate remaining unchanged, resulted in a major fall in
levels of plasma cholesterol and phospholipids in all subjects*
Other studies^»24,25,32,84,90,96,102 have reported
similar results using unsaturated fats to reduce serum choles
terol.

Such programs must be carefully controlled to produce

a significant reduction in serum cholesterol.

Various agents

designed to lower cholesterol levels also have been reported.
Studies concerning the following agents, however, did not in
clude a dietary program which established a qualitative fat
intake:

triparanol (MER-29), diiodothyroacetlc acid (Dlac),

dextrothyroxine (d-T^), and 3-methoxy-l6 alpha-methyl-1,3,5>
(10)-estratriene-16 beta, 17 beta-diol (Manvene or Anvene).
It was the purpose of this study to determine the effect
of a high unsaturated-low saturated fat diet on the serum cho
lesterol levels of clinic patients receiving these hypocholesterolemic agents.
Importance of the study.

Human studies have the

obvious advantage of the elimination of species differences.
Conditions which resemble human atherosclerosis have been
produced in a variety of experimental animals, however,
responses of these animals to nutritional and pharmacologic
agents are not necessarily comparable to those of the human.
Perhaps in no other field is this more apparent than in
research pertaining to vascular disease.

The characteristic

retinal-renal disease associated with diabetes is nearly
Impossible to produce in experimental animals.

Increased

3
nutritional understanding resulting from human studies may
provide a prophylactic or therapeutic approach to atheros
clerosis and diabetic vascular disease*

CHAPTER

II

mnw OF THE LITERATURE
.s

Two major theories have evolved from epidemiological,
clinical-pathological, and experimental animal research
They are the theory of
thrombosis^ and the fat-atherosclerosis hypothesis, 20,22,
57,59,86,91 The studies reported Indicate the possible

pertaining to coronary heart disease,

relationship of both as factors In the pathogenesis of
atherosclerosis, but for the purpose of this study, the
emphasis will be on the latter,

It states that dietary fat

ingestion, particularly a high percentage of saturated fats
or a high saturated-to-unsaturated fat ratio, is a major
factor in atherogenesis.
I.
Amsterdam

FAT-ATHEROSCLEROSIS HYPOTHESIS
10

in discussing the relationship of diet

to atherosclerosis made the statement that nthe increasing
amount of saturated and hydrogenated fat in the diet has
Imposed a strain on lipoprotein metabolism, resulting in
the elevation of certain cholesterol-lipoprotein complexes
and their infiltration into the intima of the arterial
system.”

The ingestion of these saturated fatty acids over
■X

a period of years has been reported by many Investigators-'
13,19,35,42,50,54 as a major influence in the genesis of

atherosclerosis,

5
numerous studies 11,12,23,65,74,75,77,83,93

dealing with the polyunsaturated fatty acids also support
this theory by results which indicate that these fats are
cholesterol lowering and appear to be antiatherogenic.
Epidemiological studies, such as those of Groom,
Keys,^1 or Yater,101 probably have been most responsible for
the establishment of the fat-atherosclerosis hypothesis.

The

data accumulated from such studies also have been the bases
for some of the major criticisms of this theory.

One argu

ment is that statistical increase in mortality from coronary
atherosclerosis is more apparent than real.

Another criticism

is that world-wide surveys are not an accurate index of
dietary fat consumption.

Walker and associatesfeel that

studies have indicated a greater correlation between dietary
protein and atherosclerosis than that of dietary fat.

£his

theory was discussed recently in Nutrition Reviews.

Waddell106

presented the role of carbohydrate metabolism in atherosclero
sis.

Bragdon,^ in studying this influence in the rat, pro

posed that ingestion of carbohydrate effects serum lipids
and lipoproteins.
80 and
Page, Stare, Corcoran, Pollack, and Wilkinson''"
Stare, Van Itallie, McCann, and Portman^ summarized the
evidence both for and against the fat-atherosclerosis hypo
thesis, and presented the following conclusion:

watheros-

clerosis is a multifaceted disorder in which dietary fat
is an important factor but difficult to disentangle from

6
caloric balance changes in body weight, exercise, and such
endogenous factors as sex, hemodynamics, genetics, and
various environmental influences, such as stress. Ahrens2*
4
is of the same opinion. Although he agrees that serum
lipids are affected by both the quality and quantity of the
fat ingested, he feels that evidence is not conclusive enough
to

recommendations for drastic dietary changes by

the general population.
II.

FACTORS INFLUENCING SERUM CHOLESTEROL
AND ATHEROSCLEROSIS

The correlation between high serum cholesterol levels
and atherosclerosis has been supported by pathological studies,
which established the cholesterol content of atherosclerotic
plaques.

Further evidence of the association is derived from

the fact that certain non-related disease processes with
characteristic high serum cholesterol levels show a much
higher incidence of atherosclerosis. These include diabetes,^
nephrosis. 29,68 hypothyroidism,^ and essential hyperlipemia. 104
Because of these relationships and the physiological, patholo
gical, and clinical importance of cholesterol, there are many
incentives for studying its metabolism.
Endogenous factors.
age, sex.

These factors include heredity,

Because serum cholesterol is influenced by so

many environmental factors, it has been difficult to clearly
separate genetic incluences from family habits in related

7
people.

It is possible that the variability of individual

responses to the same environmental factor may be accounted
for by genetic factors,

A recent study on age^ proposed

that blood cholesterol levels increase with age and that these
levels are not necessarily influenced by over- or undernutrition In terms of body weight.

The same report indicated

a general but significant rise in the blood cholesterol
level of many Individuals between the second and sixth decade
of life, followed by a fall in blood cholesterol level during
the subsequent decades,

Albanese

referred to a study on

age which suggested that the peak of the blood cholesterol
curve occurs one decade later in women than it does in men,
Boyd15 has reviewed the relationships of hormones on
circulating lipids.

Hormones and conditions which raise

plasma cholesterol include:

menopause, pregnancy, diabetes,

myxoedema, bilateral ovariectomy, and androgens.

Thyrotoxi

cosis, ACTH, cortisone, thyroxine,1^ and estrogens
appear to lower plasma cholesterol.

The concentration of

circulating lipids is dependent upon changes in hepatic
cholesterol biosynthesis, degradation and excretion, inter
changes in the plasma volume.

Hormones may affect the

concentration of the circulating lipids by influencing
any of these parameters. 15*4-9

8
Exogenous influences.

Studies on geographical factors,

seasonal changes, physical and emotional stress have not
demonstrated consistent results.

This is probably because

of the difficulties Involved in determining which factor
was responsible since they are so interrelated.

At the present

time, studies do indicate some effect of stress on cholesterol
level, but little is known about the seasonal or geographi
cal factors.
An exogenous Influence which has received a great deal
of attention is diet.

In human and animal experimentation

alike, numerous dietary interrelationships have been esta
blished as factors in atherogenesis and hypercholesterolemla.

These relationships primarily involve dietary fat
ingestion. 87,88
It is surmised that a chronic relative insufficiency
of unsaturated fatty acids has been created by the increased

percentage of saturated and hydrogenated dietary fat and the
high saturated-to-unsaturated fat ratio in our modern
diets,
Bronte-Stewart 21 implied that increased saturated
fat intake creates an increased requirement for the essential
fatty acids, which form a considerable proportion of the
fatty acids esterlfied with cholesterol.

An

A deficiency of

the essential fatty acids results in esterification with the
saturated fatty acids provided by dietary fat or synthesized
endogenously from carbohydrates.^

Amsterdam10 indicated that

this saturated fatty acid-cholesterol-proteln complex, less

9
soluble in plasma and more difficult to metabolize, pro
duces elevated serum lipids and eventual deposition of these
lipoprotein complexes in the intlma of high-pressure arteries.
The onset of the deficiency may be accelerated by hypercho
lesterolemia in the animal, whether it be from hypothyroidism,
diabetes, the feeding of cholesterol or hydrogenated fat.
Presumably, this is caused by the draining of linoleate from
the body-stores for esterification of cholesterol.

pi

Aaes-

Jorgensen1 and Holman^2 have thoroughly reviewed the
literature on essential fatty acids.
A simple withdrawal of saturated fatty adds from the
dlet does not explain the fall in serum cholesterol levels.
Gordon^ has reported that oils of high iodine value can
depress the serum cholesterol to a level lower than that
attained on a fat-free diet.

Ahrens and his group2*" observed

a rise in triglycerides when the proportion of calories from
fat was reduced to 10 per cent,

This has not been seen when

these oils of high iodine value were fed.
Albrlnlc^ has suggested from the results of his studies
that an error in triglyceride metabolism may be the lipid
abnormality operative in coronary artery disease.

His inves

tigation Indicated that the level of serum triglyceride is the
best measure for distinguishing the normal from coronary
subjects.
Gordon44,45 reported that feeding oils of high iodine
value after a fat-free diet produced a sharp increase in the

to
fecal sterols and bile acids, the breakdown products of
cholesterol from the body.

It is also possible that this

could be due as much to a slower elimination or to an
increased synthesis of cholesterol for the transport of the
more saturated fatty acids,

Lewls^1 and Portman^ have also

supported this theory.
A theory proposed by Schroeder,^ states that since
the most important essential fatty acid, arachidonic, may
be synthesized in the body from llnolelc acid in the presence
of pyridoxine, a deficiency of pyrldoxine may also be
responsible for atherosclerosis. This was not confirmed in
97
Shah’s study.
however, in which pyrldoxine deficiency
did not alter either the synthesis or the excretion of
cholesterol.
Current concepts now being investigated are briefly
summarized.

The effects of different dietary fats upon

human serum cholesterol levels are probably?

(l)

Best

correlated with iodine number or the over-all degree of
unsaturation. 6,21,63,73,83 (2) Studies done by Keys^
indicated that the effect can be explained by the amounts of
saturated and polyunsaturated fatty acids in the diet, the
monounsaturated fatty acids having no effect.

(3)

Klnsell63”

67 Interpreted the effect as a reflection of the essential
fatty acid or llnolelc acid content,

Several investigators
have worked on the effects of hydrogenation. 41,75,109
(4)

Bronte-Stewart and associates2-^ studied the effects of
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different dietary fats*

It was found that the addition of

a highly saturated fat to a highly unsaturated fat does not
increase the lowered serum level produced by the unsaturated
fat.

This is true if the intake does not exceed the maximum
ratio the subject can utilize, 35,65 Other data indicated
that probably a minimum ratio of acids exists.

This ratio

must be exceeded before a change in dietary fat composition
will have a significant effect in decreasing serum cholesterol
levels.

Undoubtedly the ratio varies somewhat with age,

and health, and the proportion of proteins and carbohydrates^0
in the dlet.^2*^
Kinsell 64

has summarized the dietary approach to the

problem of vascular disease in the diabetic patient.

"Well

documented observations that diets containing relatively
large amounts of polyunsaturated fat, modest amounts of
carbohydrate, adequate amounts of protein, and limited amounts
of saturated fat are associated with normal levels of blood
lipids."

It is hoped that maintenance of such blood lipid

levels will produce both prophylactic and therapeutic
results.
III.

HYPOOHOLSSTEEOLEMI0 AGENTS

The endogenous biosynthesis of cholesterol is thought
to proceed in the following steps: 29,30,34,47,69,70,72
Acetyl-CoA condenses to form acetoacetyl OoA which with
the addition of one more acetyl OoA and a decarboxylation
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produces dimethylacrylate which is a 5 carbon unit,

There fol-

lows a condensation of six of these units through various
steps to form the long chain hydrocarbon squalene.

The

squalene cyclizes and forms cholesterol by losing three
methyl groups.
Leckert?0 has summarized the ideal characteristics of
a satisfactory inhibitor of cholesterol biosynthesis.
It must be nontoxic at inhibitory levels.
It should be water soluble and absorbable from the
human gastrointestinal tract. It must inhibit
tissue synthesis as well as reduce serum levels.
It should act after acetyl ooenzyme A and before
the cycllzation of squalene. An inhibitor
acting after acetyl coenzyme A is preferable
because this compound is derived mostly
from fat catabolism. If the inhibitor acted
after squalene had undergone cycllzation
to form the steroid nucleus, there would
result a cholesterol precursor that might be
atherogenic itself.
Many hypocholesterolemic agents 39,43,81 have been
developed but only four agents, which were used in the
following study, will be discussed.

They are triparanol

(MJSR-29), diiodothyroaeetlc acid (Diac), dextrothyroxine
(Dt^), and 3-methoxy-l6 alpha-methyl-1,3*5, (10)-estratriene16 beta, 17 beta-diol (Manvene or Anvene).
Triparanol. (MJBR-29h

Triparanol resembles a synthetic

estrogen, chiorotrianisene, and an estrogen antagonist*
MER-25*

Unlike the other two substances, the structure of

triparanol gives it the property of Interference in choles
terol biosynthesis.

Thus it reduces serum cholesterol,

but is neither an estrogen nor an estrogen antagonist.

This
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compound inhibits the synthesis of cholesterol In the liver.
The site of action of trlparanol is considered to be at the
level of conversion of 24-dehydrocholesterol to cholesterol/-*
but it does not interfere with the esterification of choleste70
rol.
Because MER-29 inhibits cholesterol synthesis after the
cyclization of squalene to form the steroid nucleus, it is
possible that an atherogenic precursor of cholesterol may
accumulate.

Studies must be continued for a longer period of
time before this can be definitely established,70 There have

been no Indications of hepatic, hematologic or renal toxicity.
and it is thus far considered to be a non-toxic drug for the
reduction of the serum cholesterol. 51,70,73,76
Bilodothyroacetic acid. (Dlao).
acid is a thyroxine analogue.

Diiodothyroacetic

The literature deals only with

thyroxine analogues in general.

Safety requires that these

substances produce a greater effect on serum cholesterol
than on the myocardium.

Bextro-isomers have thus far shown

a more favorable effect than the laevo-isomers.

Although a

fairly wide margin exists between the dose required to lower
cholesterol and the dose which results in myocardial effects,
the tendency to angina was increased in a proportion of the
subjects by all the analogues studied by Boyd.1^
Bextrothyroxine. (d-T;,).

Several studies similar to

the ones referring to Biac have been made of various deriva
tives of thyroxine in the hope that one of these analogs
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would lower serum cholesterol without elevating basal
oxygen consumption. 16 Starr 99-101 has reported that sodium
dextrothyroxine can reduce the serum cholesterol concentra
tion in myxedematous patients in a dosage which does not
raise the basal metabolic rate or potentiate the electrocardiogram.

Studies cited by Starr^ indicate that this

drug lowers the serum cholesterol level in euthyroid
idiopathic and diabetic hypercholesterolemic patients.
3-methoxy-16 alpha-methyl-1.3.5. (10)-estratrlene16 beta. 17 beta-diol (Manvene or Anyone).

Varying doses

of an estrogen analog, Manvene, were administered to middleaged men with coronary heart disease.

Curing the 6-month

period of therapy estrogenic side effects and changes in
serum lipids were observed.

A dosage of 5 to 10 mg. daily

produced significant lipid-shifting effects.

The reduction

was not comparable, however, to another agent, Premarin.

CHAPTER

III

METHODOLOGY
I.

SELECTION OP SUBJECTS

Thirty-nine of the patients regularly seen in special
metabolic clinics of the White Memorial and Los Angeles
County hospitals were interviewed as possible candidates for
the study.

Prom this group 15 subjects, 6 men and 9 women,

were chosen by medical evaluation, clinical records, and
and the presence of hypercholesterolemia, unrelated to blood
glucose levels.
The interview was designed to ascertain
dietary understanding, (2)
(3)

patient1s

personal attitude toward diet,

number of meals eaten away from home, (5)

daily food intake, (6)

(l)

approximate

financial status, and (7)

willing

ness and capacity to cooperate in the proposed study.
The physician1s evaluation of the patient's reliability
and cooperation in the clinic environment, current therapy,
and physical condition were established.

The past medical

history, with particular reference to clinical chemistry
studies and responsiveness to various treatment modalities,
were determined *to serve as spheres of reference for the
present study.

1
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II•

EXPERIMENTAL DESIGN

Eleven of the patients were diabetic and familiar
with the exchange system of diets established by the American
Diabetes Association and American Dietetic Association.
Por this reason and for uniformity this system was used as
a basis for the diet prescription for all subjects, both
diabetic and non-diabetic.
The usual diet of each patient was determined during
the original interview. ill

This inventory was evaluated

for total fat and calorie consumption, and served as a basis
for planning the new diet*

Unless the intake was signifi

cantly different (within 50 calories) than the most recent
dietary prescription, the only diet change was in the nature
of the fat consumed.

When indicated, reestablishment of the

prescribed caloric Intake was advised.
The caloric distribution of all the diets was the
same.

Approximately 40 per cent of the ■fetal calories were

from carbohydrate, 20 per cent from protein, and 40 per cent
from fat.

Table I, page 17 represents the gram distribution

of carbohydrate, protein, and fat of the diets used, based
on the patterns established by the American Diabetes Associatlon.26

In addition. Table I, page, 17 Indicates the grams

of unsaturated fat, which constituted the single intended
variable of this investigation.

With total calories unchanged

and fat still constituting 40 per cent of these, the fat
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intake was altered qualitatively to approximately 70 per
cent unsaturated and 30 per cent saturated.

TABLE

I

COMPOSITION OP STANDARD DIETS
Calories

1200

1500

1800

2000

120

150

180

200

Protein, gm.

70

70

90

95

Pat, total gm.

50

70

80

90

Saturated, gm*

25**

20

25

30

Unsaturated, gm.*

25

50

55

60

Carbohydrate, gm.

*A.D.A. diet establishes no qualitative
differentiation for fats.
♦^Saturated fat in 1200 calorie diet exceeded
30^ level to provide adequate protein intake.
i
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None of the diets contained less than 50 grams
total fat.

The usual total caloric distribution was in

thirds, or one-third for each meal.

For two patients with

ulcers, meals were divided into six daily feedings.
Diet instructions were given each patient with special
emphasis on the nature and Importance of the fat prescrip
tion.

The exchange lists were reviewed with the patient,

who then chose sample menus to demonstrate his understand
ing of the diet pattern.
The allowance of saturated fat was automatically
consumed in the meat exchanges of the diet.

It was necessary,

therefore, to restrict any other sources of saturated fat.
The following foods were not to be used:

whole milk, cream.

ice cream, protein sources with high fat content (average
allowed. 5 gm. of fat/l oz. portion)^ ^

commercially

fried foods, gravies, sauces, or commercial salad dressings.
butters, margarines, or shortenings.

Eggs were restricted

to 3 a week.
Subjects were instructed to choose the fat allowance
from unsaturated sources.
an unsaturated fat was:

The general rule for selecting
unhydrogenated vegetable fats were

preferred to animal fats or hydrogenated vegetable fats.
On this basis the major sources of fat were corn oil and
any one of several polyunsaturated margarines.

Within the

limits of the fat allowance these could be used in food
preparation, for seasoning, salad dressing, or frying.
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Meat, fish, and poultry were allowed, under the previously
mentioned restrictions, if all visible fat was trimmed away
and if cooking technique permitted maximum fat drainage or
loss.

Roasting, broiling, or boiling were methods recommended.
Reassurance was given the subject by the physician

that the new dietary program constituted no break in therapy
for the hypercholesteremlc state.

Inasmuch as possible, the

insulin, oral hypoglycemic agent, exercise, and environmental
factors were maintained unchanged during tie study.

Sight

subjects were on diet therapy alone; the other subjects
received diet therapy plus agents designed to lower blood
lipid levels.

All but one subject previously had been tried

on at least one such agent.

Hypocholesteremic agents used

during the study included!

triparanol (MSR-29), diiodothy-

roacetic acid (Dlac), dextrothyroxine (d-T^), and 3-methoxy16 alpha-methyl-1,3,5# (10)-estratrlene-16 beta, 17 betadiol (Manvene or Anvene).
All subjects were seen at approximate monthly
Intervals at which time fasting blood for glucose and lipid
studies was obtained.
seen by the physician.

The patients were weighed and then
Dietary inventories were taken and

diet instructions reviewed.
Pasting venous true glucose levels were deternined by
the Sunderman-Puller method, 103 and total serum cholesterol
by the Pearson, Stearn, and McGavick method. 8?
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III.

PROCESSING- THE RATA

A clinical summarization of each subject is shown
in Table II, page 21.

The weight was a mean value estab

lished from weights recorded for a period of 4 months
prior to the beginning of the study.
mic agent used Is indicated.

The hypocholesterole-

Any condition or vascular com

plication which could influence the results of the inves
tigation are shown.

Reliability refers to the patient’s

cooperation and sincerity throughout the study.
Pour months of observation prior to the initiation
of the study were designated as Period I, and the experiment
as Period II.

Weight, serum cholesterol,^^2 and serum

glucose were chosen as the data of primary importance and
were statistically compared.

TABIE II
CLINICAL SUMMARIZATION OF SUBJECTS
t
:
s
*
5
* Uoration *
* T. . , . 8 „ .
8
j Height s; Frame 1 Drug*^ • Diet : ReliaNo • s Age sRace s Sex :of Diabetes: Complications :
* Calories: bility
: Pounds : Inches :
:
3
:
3
3
Years

1*
2
3

33
67
78

W
¥

M
F

W

F

15
7

ii

5>2

W

F

5

5
6

63
72

w
¥

F
F

9
7

7**

36

¥

M

8

62

N

F

9*

27

W

M

10

63

¥

F

n

la

N

F

12x

0

M

13

33
h3

¥

M

8

1U

75

N

M

25

15

7h

W

M

20

Xanthomatosis
A.S.H.D.*^
Diabetic
Retinopathy
Allergic
Diathesis

131
136

704”

s

Mer/29
Mer/29
Anvene

2000
1500
1500

Poor
Average
Poor

M
M

115

62 l/8«
62|»

168

60i«

M

None

1200

Average

156

624”

M

None

1200

Average

156

62-4”

M

None

1200

Average

Xanthomatosis
Duodenal ulcer
A.S.H.D.***

181

66w

Diac

1500

Average

115

604»

S

Anvene

1800

Poor

Xanthomatosis

16U

68J”

M

None

1200

Good

27

139

62«

M

None

1200

Average

2

131

68**

S

None

i5oo

Average

122

624**

M

Diac

1800

Average

20B

67 3/!t"

L

d-Tlt

1500

Poor

119

65J”

S

None

1200

Good

U*8

61 1/8"

M

None

1500

Poor

1

Xanthomatosis
A.S.H.D.***
Diabetic
Retinopathy
Diabetic
Retinopathy
Ulcer

^Patient not diabetic
^liypo cho le s tero lemic agents
Arteriosclerotic (Coronary Heart) Disease

CHAPTER

IV

RESULTS ART) DISCUSSIOR
Weight, serum glucose and cholesterol means for
periods I and II, with the differences of the means are
shown in Table 3, page 23.

Also included is the maximum

response of serum cholesterol to current therapy and the
week in which this occurred*
I.
Case 1.

RESULTS

The maximum response of serum cholesterol

during the study period was *8.3 per cent at the third week.
The difference of the means for periods I and II were:
weight, *4, serum glucose, -5» and serum cholesterol, +18.
These data were tabulated in Table III, page 23.

Ihe

actual levels of serum glucose and cholesterol with corres
ponding dosages of Mer-29 are shown in Pigure 1, page 24.
Case 2.

The maximum response of serum cholesterol

during the study period was -10.0 per cent at the eighth week.
The difference of the means for periods I and II were:
-3, serum glucose, *2?, and serum cholesterol, -20.
data were tabulated in Table III, page 23.

weight,

These

The actual levels

of serum glucose and cholesterol with corresponding dosages
of Mer-29 are shown in Pigure 2, page 25.
Case 3.

The maximum response of serum cholesterol

TABLE III
WEIGHT, SERUM GLUCOSE, AMD CHOLESTEROL MEANS FOR
PERIOD I AND II, DIFFERENCES OF THE MEANS,
AND MAXIMUM RESPONSE TO PRESENT THERAPY
•gjjSSm

Weight

Case No.

Pounds

II

D

135
133

+U

6
7*

131
136
115
168
156
156
181

8
9*

I

Maximum Response
to
Present Therapy

Serum

Cholesterol
(mg./$)
I

II

D

I

II

D

Weeks Occurred

88

-5

U22

+18

+27

322

-16
+31

317
271

i^O
302
287

258

-13

+11

277

288

+n

+21

238

239

+1

no

-5

170
158

+2
+2

93
159
iia
185
172

153

-3

m

127

186
125
216
183
11*8

-7

100

98

-2

U55

280

-175

+8.32/3
-10.02/8
-10.82A
-11.02/8
+H.92A
+6.32/10
-U6.12/9

n5

n7

+2

no

n8

+8

iai

U7U

+63

+21.62/11

16U

156

-8

92

105

+13

1*26

1*71

+1*5

+20.02A

10

139

139

0

i5o

163

+13

278

302

+21*

+17.62/2

11

139
125

+8

108
id

-75
-9

1*27

+3

183
no

268

12 *

131
122

255

21*3

+159
-12

+68.62/9
+1U.12/8

13

208

209

+1

181*

197

+13

91*3

870

-73

-25.32/8

11*

n9

ns

-1

117

99

-18

259

267

+8

+6.62/8

1
2
3

k

5*

15

11*8
Total

136

-3

-12
-17

^Patient not diabetic

172

21*3

+71
+83

311

329

-20
-30

+18
+11*

+20.22/7

to

v*i
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during the study period was -10.8 per cent at the fourth
week.

The difference of the means for periods I and XI were:

weight, -5» serum glucose, -16, and serum cholesterol, -30.
These data were tabulated in Table III, page 23*

The

actual levels of serum glucose and cholesterol with corres
ponding dosages of Anvene are shown in figure 3, page 27.
Case 4.

The maximum response of serum cholesterol

during the study period was -11.0 per cent at the eighth
week.

The difference of the means for periods I and II were:

weight, +2, serum glucose, +31, and serum cholesterol, -13.
These data were tabulated in Table III, page 23.

The actual

levels of serum glucose and cholesterol are shown in
Figure 4, page 28.
Case 5.

The maximum response of serum cholesterol

during the study period was +11.9 per cent at the fourth
week.

The difference of the means for periods I and II

were:

weight, +2, serum glucose, +11, and serum cholesterol,

+11.

These data were tabulated in Table III, page 23.

The

actual levels of serum glucose and cholesterol with corres
ponding dosages of Anvene are shown in Figure 5, page 29.
Case 6.

The maximum response of serum cholesterol

during the study period was +6.3 per cent at the tenth week.
The difference of the means for periods I and II were:
weight, -3, serum glucose, +21, and serum cholesterol, +1.
These data were tabulated in Table III, page 23.

The actual

levels of serum glucose and cholesterol are shown in Figure
6, page 30.
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Case ?•

The maximum response of serum cholesterol

during the study period was -46.1 per cent at the ninth
week.

The difference of the means for periods I and II

were:

weight, -7, serum glucose, -2, and serum cholesterol,

-175.

These dat6 were tabulated in Table III, page 23.

The actual levels of serum glucose and cholesterol with
corresponding dosages of Dlac are shown In Figure 19 page
32,
Case 8.

The maximum response of serum cholesterol

during the study period was *21,6 per cent at the eleventh
week.

The difference of the means for periods I and II

were:

weight, 4-2, serum glucose, +8, and serum cholesterol,

+63.

These data were tabulated in Table III, page 23.

The

actual levels of serum glucose and cholesterol with corres
ponding dosages of Anvene are shown in Figure 8, page 33.
Case 9.

The maximum response of serum cholesterol

during the study period was +20,0 per cent at the fifth
week.

The difference of the means for periods I and II

were:

weight, -8, serum glucose, +13, and serum cholesterol,

+45.

These data were tabulated in Table III, page 23.

The actual levels of serum glucose and cholesterol with
corresponding dosages of Mer-29 are shown in Figure 9, page
34.
Case 10.

The maximum response of serum cholesterol

during the study period was +17.6 per cent at the second
week.

The difference of the means for periods I and II

32
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were:
+24.

weight, 0, serum glucose, +13, and serum cholesterol,
These data were tabulated in Table III, page 23.

The

actual levels of serum glucose and cholesterol are shown in
Figure 10, page 36.
Case 11.

The maximum response of serum cholesterol

during the study period was +68.6 per cent at the ninth
week.

The difference of the means for periods I and II

were:

weight, +8, serum glucose, -75, serum cholesterol,

+159.

These data were tabulated in Table III, page 23.

The levels of serum glucose and cholesterol with corres
ponding dosages of Diac are shown in Figure 11, page 37.
Case 12.

The maximum response of serum cholesterol

during the study period was -14.1 per cent at the eighth
week.

The difference of the means for periods I and II

were:

weight, +3, serum glucose, -9, and serum cholesterol,

-12.

These data were tabulated in Table III, page 23.

The

actual levels of serum glucose and cholesterol with corres
ponding dosages of Diac are shown in Figure 12, page 38.
Case 13.

The maximum response of serum cholesterol

during the study period was -25.3 per cent at the eighth
week.

The difference of the means for periods I and II were:

weight, +1, serum glucose, +13, and serum cholesterol, -73.
These data were tabulated in Table III, page 23.

The actual

levels of serum glucose and cholesterol with corresponding
dosages of Diac and Dt^ are shown in Figure 13, page 39.
Case 14.

The maximum response of serum cholesterol
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during the study period was +6.6 per cent at the eighth
week.

The difference of the means for periods I and II

were:

weight, -1, serum glucose, -18, and serum choles

terol, +8.

These data were tabulated in Table III, page 23.

The actual levels of serum glucose and cholesterol with
corresponding dosages of Her-29 are shown in Figure 14,
page 41.
Case 15.

The maximum response of serum cholesterol

during the study period was +20.2 per cent at the seventh
week.

The difference of the means for periods I and II

were:

weight, -12, serum glucose, +71# and serum choles

terol, +18.
f 23.

These data were tabulated in Table III, page

The actual levels of serum glucose and cholesterol with

corresponding dosages of Anvene are shown in Figure 15#
page 42,
The total difference of the weight means was not
significant.

In the majority of the subjects there was

very little weight fluctuation during the study as shown in
Table III, page 23.

The exceptions were cases 7 and 9 who

were on reducing programs.
complaint for several weeks.

Case 15 had a gastrointestinal
During this time she was placed

on a bland diet with six feedings.

This diet followed the

same prescription as the other diets used for the study.
There was a wide range of differences in serum glucose
as indicated in TaHe III, page 23.

However, the total

difference of the serum glucose means was not
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significant.

Case 11 had the maximum change, -75«

Figure

11, page 37, indicates that this patient was subject to great
fluctuations in serum glucose.

Case 15» which had the

greatest weight change, also had a serum glucose change of
+71.

Both changes are probably best explained by the gastro

intestinal distress which occurred during the time of the
study.
The total difference of the means for serum choles
terol was not significant.

The greatest decrease was

-175 and is explained by an increased dosage of drug, see
Figure 7* page 32,

Case 11 showed a change of +159.

This

patient had a wide range in serum cholesterol as well as
serum glucose, as is shown in Figure 8, page 33.

There was

no known factor to account for these fluctuations.
In order to establish a method for comparing the in
fluence of the drugs and the effect of caloric intake upon
changes in serum cholesterol, Table IV, page 44, was compiled.
It indicates the distribution of percentages of maximum
change in serum cholesterol in relation to drug and caloric
Intake.
Despite great fluctuations between the means of
periods I and II, an overall decrease In serun cholesterol
was noted in 71 per cent of the patients who were on hypocholesterolemic agents.

Oonversely, 85.5 per cent of the

patients not on drug showed an overall increase in serum
cholesterol.
When the percentages of change were compared on the

44

TABLE

IV

DISTRIBUTION OB PERCENTAGES OP MAXIMUM
CHANGE IN SERUM CHOLESTEROL IN RELATION
TO DRUG AND CALORIC INTAKE
Distribution by Drug
Drug

No Drug:

-46.1
-25.3
-14.1

Distribution by Caloric
intake

* 1200
:
i

-11.0
— 10.8
-10.0

+6.3
+6.6
+8.3
+11.9
+17.6
+20.0
+20.2
+21.6

s

+68.6

:
2-11.0
:
:
:
T

1500

1800

-46.1
■*25,3
— 10.8
-10.0

+6.3
; +6.6

+8.3

t

: +11.9
+17.6
>20.0
:
i
t

4-

2000

+20.2
+21.6

+68.6
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basis of caloric intake, Table I?, page 44, it was noted
that nearly all of the patients on 1200 calorie diets had an
overall Increase in serum cholesterol.

The patients on

1500 calorie diets, however, had a decrease.

It must be

kept in mind that this observation may not be meaningful
because of the hypooholesterolemic agents being used.
The maximum response to prior therapy was compared to
maximum per cent of change in serum cholesterol during the
present study.

Table V, page 46, presents this date for

those patients which had a known response to previous agents.
The percentage of response in Oase 13 was the only
one which approached the level of decrease previously
established.

This change probably reflects the patients

response to a new therapy, shown in Figure 13, page 39,
and was not associated with the dietary program.
II.

DISCUSSION

Several factors must be considered in any dietary
study using clinic out-patients.

The subjects may fail to

control the diets, either by omission or commission.

In

this study both problems were observed.
Several of the patients had been on a very restricted
fat intake for some time.

For these people the amount of

unsaturated fat allowed on the present diet was unpalatable
to them.

It was very possible that these subjects never

ingested enough unsaturated fat to produce a significant

46

TABLE

V

COMPARISON OF MAXIMUM RESPONSE OP SERUM
CHOLESTEROL TO PAST AND PRESENT THERAPY

PaSt

jt'resenx
Response

Agent

♦8.3$
-10.0$

Mer-29
Mer-29

—10•8$

-48$

Estrogen
Thyroid
Analogue
Saflac
Estrogen

♦11,9$

Anvene
None

10

-17$

Estrogen

♦17.6$

None

13

-27$

Estrogen

-25*3

*-t4

14

-24$

Estrogen

15

-26$

Anvene

Pieggonse

Agent

1
2

-15$
-32$

3

-40$

5

Case No.

♦6.6$

None

♦20.2$

None
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change in serum cholesterol.
excess was more common.

However, the problem of

Several of the patients did not

seriously follow the dietary program.

Although the period

was short and the initial Interest good, some of the
subjects had lost interest in the program before the end
oflhe study.
It is a problem to evaluate the dietary intakes of
patients unless the actual methods of preparation have
been observed.

It is even more difficult to establish

what has been ingested if the patient frequently eats away
from home, or if he is a Compulsive1’ eater.

One patient

was a real problem because he was a ’’compulsive” eater,
who could consume enormous quantities of food during
periods of severe mental depression.

Another patient was

I

very fond of biscuits, and a third of the desserts served
at club meetings.
Factors such as these indicate a need for better
dietary evaluation and control of clinic out-patients.
Improved methods for stimulating and maintaining the
Interest of the subjects are also important if successful
studies of this nature are to be conducted.
Another problem in evaluation was to determine the
significance of the changes in serum cholesterol levels,
laboratory reports may be misleading if not Interpreted with
reference to the patient’s dietary history.
example of this problem.

Case 13 is an

It would appear that the results

48
for this individual were comparable to the previous therapy*
The dietary history, however, reveals that this is most
unlikely.

This subject was the "compulsive" eater who, for

example, consumed one-half gallon of ice cream during a
period of depression.

The maximum change of serum choles

terol was undoubtedly a reflection of the hypoeholesterolemlc agent being used*
With the dietary pattern used in the study, patients
on a low calorie intake could not avoid consuming a higher
ratio of saturated fat in order to obtain the prescribed
amounts of protein*

The possible solution to this problem

might be through the substitution of a greater proportion
of vegetable protein.
Some patients appeared to have marked changes in
serum glucose and cholesterol*

However, these variations

could not be interpreted as significant because they habi
tually seemed to have wide fluctuations.
Using serum cholesterol as the main criterion for
evaluating the efficacy of the diet, the results of this
study do not appear to be significant.

CHAPTER

V

SUMMARY AUD CONCLUSIONS
Fifteen hypercholesterolemia patients, eleven of whom
were diabetic, were placed on diets with prescribed amounts
of unsaturated fat.

The caloric distribution was 40 per cent

carbohydrate, 20 per cent protein, and 40 per cent fat.

The

level of unsaturated fat was 70 per cent of the total fat.
Hypocholesterolemic agents used were:

(MERr-29, Diac, d-T^,

and Anvene)*
Seventy-one per cent of the patients on the hypocholesterolemio agents had an overall decrease in serum cho
lesterol.

There was an overall Increase in serum choleste

rol in 85.5 per cent of the patients not on drug therapy.
There was no significant change observed in weight, serum
glucose, or serum cholesterol.

Using serum cholesterol as

the main criterion for evaluating tie efficacy of the diet, the
results of this study do not appear to be significant.
In view of these results the following recommendations
are made for a series of studies with patients whose res
ponse to these hypocholesterolemic agents has been esta
blished.

With the use of a good method of motivating

patients to follow diets, variables which could be investi
gated are:
and (2)
changes.

(l)

study in which total fat content changes,

study in which the level of the unsaturated fat
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ABSTEA.OT

The effect of a high unsaturated-low saturated fat
diet on serum cholesterol levels was studied.

Subjects

were clinic patients receiving the following hypochoiesterolemic agents:

triparanol (MSK-29), diiodothyroacetic

acid (Diac), dextrothyroxine (d~T4), and 3-methoxy-16,
alpha-methyl-1,3,55 (10)-estratriene-16 beta, 17 beta-diol
(Mianvene or Anvene),
fifteen hypercholesterolemic patients, eleven of whom
were diabetic, were placed on diets^4th prescribed amounts
of unsaturated fat.

The caloric distribution was 40 per

cent carbohydrate, 20 per cent protein, and 40 per cent
fat.

The level of unsaturated fat was 70 per cent of the

total fat. Seventy-one per cent of the patients on the hypoeholesterolemic agents had an overall decrease in serum
cholesterol.

There was an overall increase in serum

cholesterol in 85.5 per cent of the patients not on drug
therapy.

There was no significant change observed in weight,

serum glucose, or serum cholesterol.
Using serum cholesterol as the main criterion for
evaluating the efficacy of the diet, the results of this
study do not appear to be significant.
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